Bioactive Compounds
-
BA3527 DRI-C21045Summary: DRI-C21045 is a potent and selective inhibitor of co-stimulatory protein-protein interactions (PPIs). - BA1522 AmbazoneSummary: Ambazone is an antitumor agent with oral activity and membrane activity.
-
N2415 Licochalcone C - BA3526 TNF-α-IN-2Summary: TNF-α-IN-2 is a potent and orally active tumor necrosis factor alpha inhibitor.
- BA1521 Rf470DLSummary: Rf470DL is a rotor fluorescent D-amino acid (RfDAA).
- BA3525 HS-276Summary: HS-276 is an orally effective and highly selective inhibitor.
-
BA1520 ND-011992Summary: ND-011992 is a reversible and selective quinazoline inhibitor targeting quinone reductase and quinone oxidase. -
N2414 GC; (-)-gallocatechin - BA3524 TulisokibartSummary: Tulisokibart (PRA023) is a humanized mouse IgG1-κ type antibody.
- BA1519 VoxvogananSummary: Voxvoganan (LTX-109) is a topical antimicrobial agent that is very effective with a MIC of 2-4 μg/mL.